Colonic Diseases Clinical Trial
Official title:
Evaluation of PillCam™ Colon 2 in Visualization of the Colon
Evaluate accuracy of PCCE-2 in detecting patients with colonic polyps as compared to conventional colonoscopy.
Standard evaluation of subjects with suspected colon diseases includes endoscopic imaging by
colonoscopy and radiology testing such as: air-contrast barium enema, abdominal/pelvic CT, or
virtual colonoscopy.
The Given® Diagnostic System offers an alternative approach for endoscopic visualization of
the colon. Advantages of the Given® Diagnostic System include the elimination of the need for
conscious sedation, the minimally invasive, painless nature of the exam, and the ability to
pursue normal daily activities immediately following the procedure . Furthermore, compared to
standard colonoscopy, the Given® Diagnostic System may be more readily accepted by the
subjects, thereby improving subjects' willingness to undergo a diagnostic evaluation of the
colon and comply with colorectal cancer screening recommendations.
The PillCam™ SB capsule (formerly M2A® Capsule) that was cleared by the FDA- in August 2001
for small bowel evaluation has been ingested to date by more than 1,000,000 people worldwide
and is well accepted by patients and physicians as well as the professional societies.
However, adequate visualization of the colon cannot be achieved with the standard PillCam™ SB
capsule because of the anatomical and physiological properties of the colon which are
significantly different than the small bowel. Moreover, other issues that limit the
evaluation of the colonic mucosa by the standard PillCam™ SB procedure include an
unsatisfactory level of colon cleanliness and slow progression of the PillCam™ SB capsule
through the colon during the desired examination time. Therefore, the development and
introduction of a specially designed, customized colon capsule combined with a dedicated
capsule colonoscopy procedure protocol will allow for more efficient evaluation of the
colonic mucosa. This is expected to improve the capability of the Given® Diagnostic System to
detect colonic pathologies and to serve as a diagnostic and screening tool for colonic
disease. To date, several clinical studies have been conducted with Given® Diagnostic System
and the PillCam™ Colon 1 capsule A pilot multicenter study is currently being conducted with
a new Given® Diagnostic System and an advanced generation of the the PillCam™ Colon capsule -
PillCam™ Colon 2. Capsule. The new development of Given® Diagnostic System and PillCam™ Colon
2 capsule is primarily aimed to increase sensitivity and specificity for polyp detection.
Further details of the Given® Diagnostic System and PillCam™ Colon 2 capsule can be found in
the device description section.
This study is designed to evaluate the performance of the new version of Given® Diagnostic
System and PillCam™ Colon 2 capsule in detecting patients with polyps and other colonic
lesions as compared to conventional colonoscopy.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02503696 -
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
|
N/A | |
Terminated |
NCT01119027 -
Assessing Effectiveness of Laparoscopic Colorectal Surgical Skills
|
N/A | |
Completed |
NCT04074577 -
Computer Aided Detection, Tandem Colonoscopy Study
|
N/A | |
Not yet recruiting |
NCT04087824 -
Deep Learning Algorithm for Recognition of Colonic Segments.
|
N/A | |
Completed |
NCT03559543 -
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
|
Phase 2 | |
Terminated |
NCT02503631 -
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
|
||
Completed |
NCT01600209 -
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
|
N/A | |
Completed |
NCT01260168 -
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
|
N/A | |
Completed |
NCT00604162 -
PillCam™ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon
|
Phase 3 | |
Recruiting |
NCT04598880 -
Comparison of 1 Liter PEG With Ascorbate and Sodium Picosulfate / Magnesium Citrate for High Quality Colon Cleansing
|
Phase 4 | |
Completed |
NCT01738425 -
A Clinical Phase I Study on GIC-1001 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04080843 -
Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients
|
Phase 2 | |
Terminated |
NCT04644315 -
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
|
Phase 2 | |
Completed |
NCT02291445 -
Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study
|
Phase 2 | |
Completed |
NCT03037385 -
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03139942 -
Optical Polyp Testing for In Vivo Classification
|
N/A | |
Completed |
NCT04263818 -
Endoscopist and Endoscope Motions During Colonoscopy
|
N/A | |
Recruiting |
NCT05923918 -
A Study to Evaluate Safety and Efficacy of PBK_M2101
|
Phase 3 | |
Completed |
NCT02647866 -
Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
|
Phase 2 | |
Completed |
NCT01397747 -
Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
|
N/A |